These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11153768)

  • 21. Modulation by simvastatin of iberiotoxin-sensitive, Ca2+-activated K+ channels of porcine coronary artery smooth muscle cells.
    Seto SW; Au AL; Lam TY; Chim SS; Lee SM; Wan S; Tjiu DC; Shigemura N; Yim AP; Chan SW; Tsui SK; Leung GP; Kwan YW
    Br J Pharmacol; 2007 Aug; 151(7):987-97. PubMed ID: 17558433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor.
    Feleszko W; Mlynarczuk I; Nowis D
    FEBS Lett; 2001 Aug; 503(2-3):219-20. PubMed ID: 11526915
    [No Abstract]   [Full Text] [Related]  

  • 23. Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth.
    Emmanuele L; Ortmann J; Doerflinger T; Traupe T; Barton M
    Biochem Biophys Res Commun; 2003 Feb; 302(1):67-72. PubMed ID: 12593849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
    Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
    J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin.
    Draude G; Hrboticky N; Lorenz RL
    Biochem Pharmacol; 1999 Feb; 57(4):383-6. PubMed ID: 9933026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
    Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
    Cirillo P; Pacileo M; De Rosa S; Calabrò P; Gargiulo A; Angri V; Prevete N; Fiorentino I; Ucci G; Sasso L; Petrillo G; Musto D'Amore S; Chiariello M
    J Vasc Res; 2007; 44(6):460-70. PubMed ID: 17657162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
    Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
    Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
    Fouty BW; Rodman DM
    Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived growth factor-BB induces apoptosis in cultured vascular smooth muscle cells derived from human saphenous vein.
    Unlu S; Mason CD; Hughes AD
    Biochem Soc Trans; 1998 Nov; 26(4):S325. PubMed ID: 10047839
    [No Abstract]   [Full Text] [Related]  

  • 31. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
    Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
    Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of policosanol vs lovastatin on intimal thickening in rabbit cuffed carotid artery.
    Noa M; Más R; Mesa R
    Pharmacol Res; 2001 Jan; 43(1):31-7. PubMed ID: 11207063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lovastatin increases nitric oxide synthesis in IL-1 beta-stimulated smooth muscle cells.
    Chen H; Xing Y; Liu R
    Chin Med J (Engl); 2001 Nov; 114(11):1123-7. PubMed ID: 11729502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering].
    Fujita R; Matsushima T
    Nihon Rinsho; 1999 Dec; 57(12):2821-5. PubMed ID: 10638219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin, a potent HMG-CoA reductase inhibitor, inhibits the proliferation of human and bovine endothelial cells in vitro.
    Sato I; Ma L; Ikeda M; Morita I; Murota S
    J Atheroscler Thromb; 1998; 4(3):102-6. PubMed ID: 9730140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.
    Indolfi C; Cioppa A; Stabile E; Di Lorenzo E; Esposito G; Pisani A; Leccia A; Cavuto L; Stingone AM; Chieffo A; Capozzolo C; Chiariello M
    J Am Coll Cardiol; 2000 Jan; 35(1):214-21. PubMed ID: 10636283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2.
    Wächtershäuser A; Akoglu B; Stein J
    Carcinogenesis; 2001 Jul; 22(7):1061-7. PubMed ID: 11408350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
    Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
    Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
    Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.